Cargando…
Nadir CA-125 has prognostic value for recurrence, but not for survival in patients with ovarian cancer
The objective of this study was to evaluate the nadir CA-125 in patients with epithelial ovarian cancer. A total of 168 patients who achieved complete remission (no clinical and radiological signs, CA-125 ≤ 35 U/ml) after first-line treatment were enrolled in the study. The relationship between CA-1...
Autores principales: | Piatek, Szymon, Panek, Grzegorz, Lewandowski, Zbigniew, Piatek, Dominika, Kosinski, Przemyslaw, Bidzinski, Mariusz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440776/ https://www.ncbi.nlm.nih.gov/pubmed/34521891 http://dx.doi.org/10.1038/s41598-021-97564-1 |
Ejemplares similares
-
Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer
por: Piatek, Szymon, et al.
Publicado: (2020) -
Reproductive Results in Cancer Survivors after Fertility Sparing Management: The Need for the Standardization of Definitions
por: Piątek, Szymon, et al.
Publicado: (2023) -
Obstetric Results after Fertility-Sparing Management of Non-Epithelial Ovarian Cancer
por: Piątek, Szymon, et al.
Publicado: (2023) -
Nadir CA-125 level as prognosis indicator of high-grade serous ovarian cancer
por: Xu, Xia, et al.
Publicado: (2013) -
Assessment of Hospital Volume in the Surgical Management of Endometrial and Ovarian Cancer: A Polish Population-Based Study
por: Piątek, Szymon, et al.
Publicado: (2023)